PRESS RELEASE
For Immediate Release
Dated: December 16, 2004
Contact: Brooke Holve
Public Relations
Youngevity
917-755-4900


FDA POSTPONES DECISION ON LYCOPENE AND CANCER HEALTH CLAIM PETITION UNTIL FEBRUARY 11, 2005

San Diego, California - The FDA will not issue its decision on the pending Youngevity lycopene/cancer health claim petition until February 11, 2005. The FDA was supposed to issue its decision on December 24, 2004. In recent months the agency has asked for extensions in its review of seven other pending qualified health claim petitions citing a lack of agency resources.

Youngevity has submitted several Health Claim Petitions to the FDA and is responsible for the recently authorized Health Claim Petition for Selenium and its relationship to Cancer Risk Reduction. Youngevity has helped to defend the Health Claim Petition process through the courts and has submitted many official comments to the FDA on behalf of the nutrition industry, all in an effort to help consumers have more access to truthful information in order to base a more informed decision regarding their own health and wellness.

Youngevity is a leading designer of Dietary Supplements and cutting edge personal care and wellness lifestyle products. The company was founded in April of 1997 in San Diego, California by Joel D. Wallach BS, DVM, ND, and Ma Lan MD, MS. Youngevity markets its products worldwide, through a network of independent distributors.